Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Nelson

Showing results (11-20 of 317) with videos related to

Pageof 32
Sort By:
Neurology|April 16, 2026
The Clinical Diagnosis of AD, LATE, and AD+LATE: Relevant Considerations for Your Patients or Research ParticipantsPeter T Nelson, Gregory A Jicha
Progress in Neurobiology|August 2, 2011
Biomarkers and evolution in Alzheimer diseaseStanley I Rapoport, Peter T Nelson
Neurology|February 2, 2026
Tau Biomarker-Based Diagnosis of Alzheimer Disease and the Anti-Abeta Therapeutic Window: Is There Overlap?Peter T Nelson, Gregory A Jicha
Neurology|June 21, 2023
Surprising Synergy Between Cerebrovascular and Lewy Body Disease in ParkinsonismPeter T Nelson, Gregory A Jicha
Neurodegenerative Disease Management|September 20, 2011
Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic optionsGregory A Jicha, Peter T Nelson
Neuroscience Letters|April 28, 2009
In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brainPeter T Nelson, Bernard R Wilfred
Journal of Neuropathology and Experimental Neurology|June 6, 2007
RNA in brain disease: no longer just "the messenger in the middle"Peter T Nelson, Jeffrey N Keller
Acta Neuropathologica|August 6, 2025
PART and amyloid cascade hypotheses are alive and well (but are not so simple). Scientific commentary on: "Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-beta deposits"Peter T Nelson, John F Crary
Journal of Alzheimer'S Disease : JAD|April 24, 2010
MiR-107 is reduced in Alzheimer's disease brain neocortex: validation studyPeter T Nelson, Wang-Xia Wang
JAMA Neurology|March 10, 2015
Cerebrospinal fluid vascular endothelial growth factorPeter T Nelson, Gregory A Jicha
Pageof 32

Showing results (11-20 of 317) with videos related to

Sort By:
Pageof 32
Neurology|April 16, 2026
The Clinical Diagnosis of AD, LATE, and AD+LATE: Relevant Considerations for Your Patients or Research ParticipantsPeter T Nelson, Gregory A Jicha
Progress in Neurobiology|August 2, 2011
Biomarkers and evolution in Alzheimer diseaseStanley I Rapoport, Peter T Nelson
Neurology|February 2, 2026
Tau Biomarker-Based Diagnosis of Alzheimer Disease and the Anti-Abeta Therapeutic Window: Is There Overlap?Peter T Nelson, Gregory A Jicha
Neurology|June 21, 2023
Surprising Synergy Between Cerebrovascular and Lewy Body Disease in ParkinsonismPeter T Nelson, Gregory A Jicha
Neurodegenerative Disease Management|September 20, 2011
Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic optionsGregory A Jicha, Peter T Nelson
Neuroscience Letters|April 28, 2009
In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brainPeter T Nelson, Bernard R Wilfred
Journal of Neuropathology and Experimental Neurology|June 6, 2007
RNA in brain disease: no longer just "the messenger in the middle"Peter T Nelson, Jeffrey N Keller
Acta Neuropathologica|August 6, 2025
PART and amyloid cascade hypotheses are alive and well (but are not so simple). Scientific commentary on: "Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-beta deposits"Peter T Nelson, John F Crary
Journal of Alzheimer'S Disease : JAD|April 24, 2010
MiR-107 is reduced in Alzheimer's disease brain neocortex: validation studyPeter T Nelson, Wang-Xia Wang
JAMA Neurology|March 10, 2015
Cerebrospinal fluid vascular endothelial growth factorPeter T Nelson, Gregory A Jicha
Pageof 32